blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4005587

EP4005587 - PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED DYSKINESIA OR FOR SUPPRESSING PROGRESSION THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  05.07.2024
Database last updated on 30.10.2024
FormerRequest for examination was made
Status updated on  29.04.2022
FormerThe international publication has been made
Status updated on  05.02.2021
Most recent event   Tooltip15.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Peptron, Inc.
37-24, Yuseong-daero 1628 beon-gil
Yuseong-gu
Daejeon 34054 / KR
[2022/22]
Inventor(s)01 / CHOI, Ho Il
JeonMin-Dong) 37-24, Yuseong-daero 1628beon-gil
Yuseong-gu
Daejeon 34054 / KR
 [2022/22]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2022/22]
Application number, filing date20846757.129.07.2020
[2022/22]
WO2020KR10023
Priority number, dateUS201962879574P29.07.2019         Original published format: US 201962879574 P
[2022/22]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021020885
Date:04.02.2021
Language:KO
[2021/05]
Type: A1 Application with search report 
No.:EP4005587
Date:01.06.2022
Language:EN
[2022/22]
Search report(s)International search report - published on:KR04.02.2021
(Supplementary) European search report - dispatched on:EP12.07.2023
ClassificationIPC:A61K38/22, A61K38/26, A61K9/16, A61K31/198, A61P25/14, A61K9/50, A61K47/34
[2023/32]
CPC:
A61P25/14 (EP,CN,KR); A61K38/2278 (KR); A61K9/1647 (CN,KR);
A61K31/198 (EP,CN); A61K38/22 (CN); A61K38/26 (EP,CN,KR);
A61K47/34 (EP); A61K9/1641 (CN); A61K9/5026 (EP);
A61P25/16 (CN); A61K2300/00 (KR) (-)
C-Set:
A61K31/198, A61K2300/00 (EP);
A61K38/26, A61K2300/00 (EP)
Former IPC [2022/22]A61K38/22, A61K38/26, A61K9/16, A61K31/198, A61P25/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/22]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON LEVODOPA-INDUZIERTER DYSKINESIE ODER ZUR UNTERDRÜCKUNG VON DEREN PROGRESSION[2022/22]
English:PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED DYSKINESIA OR FOR SUPPRESSING PROGRESSION THEREOF[2022/22]
French:COMPOSITION PHARMACEUTIQUE POUR TRAITER LES DYSKINÉSIES INDUITES PAR LA LÉVODOPA OU POUR BLOQUER LEUR PROGRESSION[2022/22]
Entry into regional phase28.01.2022Translation filed 
28.01.2022National basic fee paid 
28.01.2022Search fee paid 
28.01.2022Designation fee(s) paid 
28.01.2022Examination fee paid 
Examination procedure28.01.2022Examination requested  [2022/22]
08.02.2024Amendment by applicant (claims and/or description)
08.02.2024Date on which the examining division has become responsible
05.07.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
28.07.2022Renewal fee patent year 03
27.07.2023Renewal fee patent year 04
15.07.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2008117927  (PEPTRON CO LTD [KR], et al);
International search[DY]KR100805208B  (PEPTRON CO LTD [KR]);
 [A]KR20130043197  (PHYTOPHARM PLC [GB]);
 [A]KR20180096733  (UNIV JOHNS HOPKINS [US]);
 [A]KR20190086460  (US HEALTH [US], et al);
ExaminationWO2018075901
by applicantKR100805208B
 WO2017US57606
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.